| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | IRMD Iradimed Corp | Hawkins James B60 | Director | Sell | 9,532 | $43.02 | $410,067.84 | -11.5% | -0.7% | +26.9% | |
| Dec 1, 2023 | ARAY Accuray Inc | Chalke Sandeep | SVP, Chief Commercial Officer | Sell | 26,799 | $1.70 | $45,611.90 | -4.8% | +2.4% | -12.2% | |
| Dec 1, 2023 | SSKN Strata Skin Sciences, Inc. | Gov Shmuel | COO | Buy | 20,000 | $0.45 | $8,955.62 | +45.0% | +14.2% | -28.2% | |
| Dec 1, 2023 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 2,868 | $10.34 | $29,655.12 | -0.4% | -17.9% | -42.6% | |
| Dec 1, 2023 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP Chief Legal Officer | Sell | 3,612 | $114.56 | $413,774.05 | -2.0% | -1.3% | -33.1% | |
| Dec 1, 2023 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 1,626 | $1.15 | $1,864.86 | - | +12.2% | -46.1% | |
| Dec 1, 2023 | ICUI Icu Medical Inc/de | Woolson Daniel56 | VP, Gm-infusion Capital | Sell | 1,729 | $88.03 | $152,196.26 | -14.9% | +19.6% | +79.5% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 394 | $12.37 | $4,873.78 | -0.3% | +27.5% | +107.3% | |
| Dec 1, 2023 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $226.42 | $135,850.56 | -0.1% | +3.1% | +7.2% | |
| Dec 1, 2023 | SYK Stryker Corp | Datar Srikant M.51 | Director | Sell | 500 | $298.22 | $149,111.50 | -11.6% | +17.2% | +31.7% | |
| Dec 1, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 7,500 | $74.40 | $558,033.25 | -0.5% | +9.3% | +16.1% | |
| Dec 1, 2023 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 3,809 | $10.34 | $39,381.04 | -0.8% | -17.9% | -42.6% | |
| Dec 1, 2023 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 45,600 | $9.07 | $413,592.00 | +21.4% | +7.9% | +133.6% | |
| Dec 1, 2023 | LUNG Pulmonx Corp | McKune John | Interim CFO | Sell | 942 | $10.34 | $9,738.93 | -0.8% | -17.9% | -42.6% | |
| Dec 1, 2023 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 394 | $12.37 | $4,873.78 | -0.9% | +27.5% | +107.3% | |
| Dec 1, 2023 | DXR Daxor Corp | Michel Robert J61 | Chief Financial Officer | Buy | 180 | $7.75 | $1,395.00 | +1.8% | +0.5% | +22.4% | |
| Dec 1, 2023 | MYO Myomo, Inc. | Kovelman Harry68 | Chief Medical Officer | Sell | 8,333 | $0.00 | - | -5.6% | -8.1% | +68.8% | |
| Dec 1, 2023 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 6,676 | $10.34 | $69,029.84 | -0.2% | -17.9% | -42.6% | |
| Dec 1, 2023 | DXR Daxor Corp | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 800 | $7.80 | $6,240.00 | +0.5% | +0.5% | +22.4% | |
| Dec 1, 2023 | ARAY Accuray Inc | Spine Patrick62 | SVP, Chief Admin Officer | Sell | 14,832 | $2.47 | $36,652.84 | -6.3% | +2.4% | -12.2% | |
| Dec 1, 2023 | ARAY Accuray Inc | Winter Suzanne C63 | President | Sell | 65,390 | $2.47 | $161,624.46 | -4.6% | +2.4% | -12.2% | |
| Dec 1, 2023 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 13,463 | $2.47 | $33,271.11 | -3.2% | +2.4% | -12.2% | |
| Dec 1, 2023 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 19,212 | $2.47 | $47,482.46 | -4.6% | +2.4% | -12.2% | |
| Dec 1, 2023 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 500 | $10.68 | $5,340.00 | +3.1% | +61.3% | +14.1% | |
| Dec 1, 2023 | ARAY Accuray Inc | Chew Jesse57 | SVP, General Counsel | Sell | 29,770 | $2.47 | $73,564.65 | -7.2% | +2.4% | -12.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.